-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Aurinia Pharmaceuticals Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2019 to Q2 2024.
- Aurinia Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $722K.
- Aurinia Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$50.3M, a 30.8% increase year-over-year.
- Aurinia Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$78M, a 27.9% increase from 2022.
- Aurinia Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$108M, a 40.2% increase from 2021.
- Aurinia Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$181M, a 76.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)